NDATOPICALLOTION
Approved
Aug 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
BETAMETHASONE VALERATE (betamethasone valerate) by Sandoz is clinical pharmacology: topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. Approved for atopic eczema, hand eczema, psoriasis. First approved in 1983.
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Betamethasone valerate is a mid-to-high potency topical corticosteroid available as a lotion formulation that reduces inflammation, itching, and vasodilation in dermatologic conditions. It works through anti-inflammatory and immunosuppressive mechanisms on the skin via unclear but measurable vasoconstrictor activity. Patients with inflammatory skin conditions such as eczema, psoriasis, and dermatitis are the typical users.
$4.0MPart D
LOE ApproachingProduct is approaching loss of exclusivity with minimal Part D spending ($4M) and modest claim volume (123K), suggesting a mature, commoditized market with limited growth headroom.
Mechanism of Action
CLINICAL PHARMACOLOGY: Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict…
Indications (3)
Worked on BETAMETHASONE VALERATE at Sandoz? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.